Belarus to launch mass production of Sputnik V vaccine on March 30-31

Belarus to launch mass production of Sputnik V vaccine on March 30-31

Belarus plans to launch mass production of the Sputnik V anti-coronavirus vaccine on March 30-31. A pilot batch is being examined by experts in Russia, Belarusian Deputy Health Minister Dmitry Cherednichenko said on Sunday, TASS reported.

"The first batch, the so-called validation batch of 15,000 ampoules, was manufactured on February 26. Now it is being examined at the Russian Gamaleya Institute (the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Health Ministry - TASS) for sustainability, efficacy, etc. We will begin to manufacture the vaccine from March 30-31. It is planned to make 500,000 doses a month," he said in an interview with the ONT television channel.

According to Cherednichenko, the key goal is to satisfy the domestic demand. "First of all, we need to vaccinate the entire population of our country. When we have a possibility for exporting the vaccine, we will supply it abroad. It is envisaged by the contract," he said.

"The Sputnik V vaccine is a vaccine that is most efficient," he stressed. "As for side effects, they are minimal. That is why we are now working with the Sputnik V vaccine and with the Chinese Sinopharm vaccine. But we don’t ignore other manufacturers. Negotiations are underway. We keep the situation under control."

He did not rule out that not only Russia’s Sputnik V would be manufactured in Belarus.